Free Trial
LON:CEL

Celadon Pharmaceuticals (CEL) Share Price, News & Analysis

Celadon Pharmaceuticals logo
GBX 27.50
0.00 (0.00%)
(As of 11/1/2024 ET)

About Celadon Pharmaceuticals Stock (LON:CEL)

Key Stats

Today's Range
25.38
30
50-Day Range
24
54
52-Week Range
20
130
Volume
26,527 shs
Average Volume
77,233 shs
Market Capitalization
£18.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Receive CEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CEL Stock News Headlines

Celadon Pharmaceuticals Plc (CEL.L)
Crypto Crash Ahead? (27 Experts Weigh In)
Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!
See More Headlines

CEL Stock Analysis - Frequently Asked Questions

Celadon Pharmaceuticals' stock was trading at GBX 115 on January 1st, 2024. Since then, CEL stock has decreased by 76.1% and is now trading at GBX 27.50.
View the best growth stocks for 2024 here
.

Shares of CEL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celadon Pharmaceuticals investors own include AutoZone (AZO), Bahamas Petroleum (BPC), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM) and Avino Silver & Gold Mines (ASM).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
CIK
N/A
Fax
N/A
Employees
2,780
Year Founded
N/A

Profitability

Net Income
£-5,230,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£11,258.00
Cash Flow
GBX 9.01 per share
Book Value
GBX 4 per share

Miscellaneous

Free Float
N/A
Market Cap
£18.93 million
Optionable
Not Optionable
Beta
-0.26
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (LON:CEL) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners